Search - tctmd.com

Displaying 41 - 60 of 74

Sort: Relevancy | Date

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Conference News ACC 2018

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Michael O'Riordan

March 01, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Features

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Ashley Lyles

July 13, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

Todd Neale

December 19, 2016

News Daily News

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

Michael O'Riordan

May 17, 2016

News Daily News

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

Michael O'Riordan

May 17, 2016

News Daily News

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Michael O'Riordan

May 17, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

Advertisement

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

New Performance and Quality Metrics for STEMI and NSTEMI Care

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content